SCHEMBL3780596

SCHEMBL3780596

CCc1ccc(-c2cncc(OCC3(CN(C(=O)O)C(C)(C)C)CC3)c2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTPS1 P17812 3/20 0.34
XDH P47989 2/20 0.34
SLC22A12 Q96S37 2/20 0.34
MKNK1 Q9BUB5 1/20 0.34
MKNK2 Q9HBH9 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
CCNC P24863 1/20 0.33
CDK8 P49336 1/20 0.33
PIK3CG P48736 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
AKT1 P31749 1/20 0.32
CHRNB2 P17787 2/20 0.32
CHRNA4 P43681 1/20 0.32
CA12 O43570 1/20 0.32
ALPL P05186 1/20 0.32
CA9 Q16790 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3776417 0.89 CHRNB1 (0.41) CTPS1XDHMKNK1MKNK2CYP11B1
SCHEMBL3774462 0.89 MAP4K4 (0.41) CTPS1SLC22A12MKNK1MKNK2CYP11B1
SCHEMBL3775792 0.89 CHRNB1 (0.41) CTPS1XDHSLC22A12MKNK1MKNK2
SCHEMBL3780254 0.87 XDH (0.40) XDHSLC22A12EGLN1CYP11B1CYP11B2
SCHEMBL3770619 0.86 CHRNB1 (0.36) MKNK1MKNK2SMN1; SMN2CHRNB2CHRNB1
SCHEMBL3780627 0.84 CYP11B2 (0.35) XDHSLC22A12CYP11B1CYP11B2CHRNB2
SCHEMBL3765825 0.83 XDH (0.40) CTPS1XDHSLC22A12EGLN1CHRNB2
SCHEMBL3765740 0.83 CYP11B1 (0.39) MKNK1MKNK2EGLN1CYP11B1CYP11B2
SCHEMBL3778997 0.83 DGAT1 (0.36) XDHEGLN1CYP11B1CYP11B2AKT1
SCHEMBL3774126 0.83 CNR2 (0.41) CTPS1XDHSLC22A12EGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100317698-A1 Polysubstituted Pyridinylaminoalkylene- and Pyridinyloxyalkylene-Cyclopropanamine Compounds, a Process for Their Preparation and Pharmaceutical Compositions Containing Them LES LABORATOIRES SERVIER (FR) 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317698-A1 Polysubstituted Pyridinylaminoalkylene- and Pyridinyloxyalkylene-Cyclopropanamine Compounds, a Process for Their Preparation and Pharmaceutical Compositions Containing Them CHRNA6, CHRNE, CHRNG CTPS1 2954/4885XDH 974/4885SLC22A12 3272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.